Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Supraventricular tachycardia: therapy with a variable antitachycardia stimulation program].

P Pfitzner1, U Gerckens, H D Funke

  • 1Medizinische Universitätsklinik, Bonn.

Zeitschrift Fur Kardiologie
|June 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of obstructive sleep apnea on heart rate turbulence.

Basic research in cardiology·2005
Same author

[Postoperative arrhythmias].

Deutsche medizinische Wochenschrift (1946)·2005
Same author

[Atrial fibrillation -- interventional therapy with respect to age].

Deutsche medizinische Wochenschrift (1946)·2005
Same author

Progression of native coronary plaques and in-stent restenosis are associated and predicted by increased pre-procedural C reactive protein.

Heart (British Cardiac Society)·2005
Same author

Atrial fibrillation: profit from cardiac pacing?

Zeitschrift fur Kardiologie·2005
Same author

[Progressive upper lobe consolidation in a 73-year old healthy woman].

Der Internist·2005

Modern pacemakers effectively treat supraventricular tachycardias using advanced pacing modes. This study shows flexible antitachycardia pacing programs significantly improve termination success rates in patients.

Area of Science:

  • Cardiology
  • Biomedical Engineering

Context:

  • Supraventricular tachycardias (SVTs) pose a significant clinical challenge.
  • Microprocessor-controlled antitachycardia pacemakers offer advanced therapeutic options.

Purpose:

  • To evaluate the efficacy of a universal antitachycardia pacing mode using the InterTach 262-12 device in the chronic management of SVTs.
  • To assess the performance of burst stimulation and scanning modes based on individual electrophysiologic parameters.

Summary:

  • The InterTach 262-12 was implanted in 17 patients (mean age 50 years) with various SVTs, including AV-nodal reentrant tachycardia and Wolff-Parkinson-White syndrome.
  • Testing every 3 months demonstrated 95-100% successful termination rates in controlled settings.
  • In chronic use, 21 of 26 persistent tachycardias were linked to detection issues, while only 4 were due to ineffective pacing.

Related Experiment Videos

Impact:

  • Flexible antitachycardia pacing programs represent a significant advancement in pacemaker therapy for SVTs.
  • Improved tachycardia detection algorithms are crucial for maximizing therapeutic efficacy.
  • This technology enhances patient management and quality of life for individuals with recurrent SVTs.